Register a FREE account
People also search for:
Nature Reviews Cancer,
Journal of Clinical Oncology,
Cell Host and Microbe,
Drug Resistance Updates,
Molecular Therapy - Oncolytics - Journal Impact
The Journal Impact 2019-2020 of Molecular Therapy - Oncolytics is
5.650, which is just updated in 2020.
Compared with historical Journal Impact data, the Metric 2019 of Molecular Therapy - Oncolytics grew by
The Journal Impact Quartile of Molecular Therapy - Oncolytics is
The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The Journal Impact measures the average number of citations received in a particular year (2019) by papers published in the journal during the two preceding years (2017-2018). Note that 2019 Journal Impact are reported in 2020; they cannot be calculated until all of the 2019 publications have been processed by the indexing agency.
In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of Molecular Therapy - Oncolytics.
5.5 ~ 6.0
Molecular Therapy - Oncolytics - Journal Impact Prediction System
50% scientists expect Molecular Therapy - Oncolytics Journal Impact 2020 will be in the range of 5.5 ~ 6.0.
Journal Impact Prediction System provides an open, transparent, and straightforward platform to help academic researchers Predict future Metric and performance through the wisdom of crowds. Journal Impact Prediction System displays the exact community-driven Metric without secret algorithms, hidden factors, or systematic delay.
Molecular Therapy - Oncolytics - ISSN
The ISSN of Molecular Therapy - Oncolytics is 23727705. An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
Molecular Therapy - Oncolytics - Open Access Journal
Molecular Therapy - Oncolytics is an Open Access (OA) Journal. Open Access stands for unrestricted access and unrestricted reuse. With Open Access, researchers can read and build on the findings of others without restriction. Much scientific and medical research is paid for with public funds. Open Access allows taxpayers to see the results of their investment.
Molecular Therapy - Oncolytics - Publisher
Molecular Therapy - Oncolytics is published by Cell Press,
which is located in the United Kingdom.
The Publication History of Molecular Therapy - Oncolytics covers 2016-ongoing.
Molecular Therapy - Oncolytics - Categories
Molecular Therapy - Oncolytics is a peer-reviewed scientific journal.
The scope of Molecular Therapy - Oncolytics covers
Cancer Research (Q1), Molecular Medicine (Q1), Oncology (Q1), Pharmacology (medical) (Q1).
Molecular Therapy - Oncolytics - Journal Factors
It is impossible to get a true picture of impact using a single Metric alone, so a basket of factors is needed to support informed decisions. In addition to
Research Hotspot and
Template, several advanced Journal Factors including
SJR (SCImago Journal Rank Indicator) and
SNIP (Source Normalized Impact per Paper) can provide you comprehensive insights into the Molecular Therapy - Oncolytics.